专利检索 ap:("Eli Lilly & Company") AND inv:"HEATH, Perry Clark" 第 1 页

1.

发明公开
1,5-DIPHENYL-3-PYRIDINYLAMINO-1,5-DIHYDRIOYRROLIDIN-2-ONES AS CB1 RECEPTOR MODULATORS 有权
标题翻译： 1,5-二苯基-3-吡啶基氨基-1,5- DIHYDRIOYRROLIDIN-2-ONE AS CB1受体调节剂

公开(公告)号：EP2099784A2

公开(公告)日：2009-09-16

申请号：EP07871196.7

申请日：2007-10-22

申请人： Eli Lilly & Company

发明人： SCHAUS, John Mehnert , HEATH, Perry Clark

IPC分类号： C07D401/12 , C07D207/38 , A61K31/4025 , A61P25/00

CPC分类号： C07D401/12 , C07D207/38

摘要： Compound and pharmaceutical compositions of Forumla by blockade of the CB1 receptors via an inverse agonism mechanism, and are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailabilty.

2.

发明授权
1,5-DIPHENYL-3-PYRIDINYLAMINO-1,5-DIHYDRIOYRROLIDIN-2-ONES AS CB1 RECEPTOR MODULATORS 有权
标题翻译： 1,5-二苯基-3-吡啶基氨基-1,5- DIHYDRIOYRROLIDIN-2-ONE AS CB1受体调节剂

公开(公告)号：EP2099784B1

公开(公告)日：2012-12-12

申请号：EP07871196.7

申请日：2007-10-22

申请人： Eli Lilly & Company

发明人： SCHAUS, John Mehnert , HEATH, Perry Clark

IPC分类号： C07D401/12 , C07D207/38 , A61K31/4025 , A61P25/00

CPC分类号： C07D401/12 , C07D207/38